Monocarboxylate Transporter 4 Is a Therapeutic Target in Non-small Cell Lung Cancer with Aerobic Glycolysis Preference

Targeting metabolic reprogramming is an emerging strategy in cancer therapy. However, clinical attempts to target metabolic reprogramming have been proved to be challenging, with metabolic heterogeneity of cancer being one of many reasons that causes treatment failure. Here, we stratified non-small...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mol Ther Oncolytics
Auteurs principaux: Kuo, Ting-Chun, Huang, Kuo-Yen, Yang, Shuenn-Chen, Wu, Sean, Chung, Wei-Chia, Chang, Yih-Leong, Hong, Tse-Ming, Wang, Shu-Ping, Chen, Hsuan-Yu, Hsiao, Tzu-Hung, Yang, Pan-Chyr
Format: Artigo
Langue:Inglês
Publié: American Society of Gene & Cell Therapy 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7364124/
https://ncbi.nlm.nih.gov/pubmed/32695876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2020.06.012
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires